Rikvin Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-06-2024
- Paid Up Capital ₹ 0.10 M
as on 22-06-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.05 Cr
as on 22-06-2024
- Satisfied Charges ₹ 5.00 M
as on 22-06-2024
- Revenue 27.80%
(FY 2021)
- Profit 59.58%
(FY 2021)
- Ebitda 31.74%
(FY 2021)
- Net Worth 79.62%
(FY 2021)
- Total Assets -0.10%
(FY 2021)
About Rikvin Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.05 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Laxmi Badarla and Trinadha Badarla serve as directors at the Company.
- CIN/LLPIN
U15549TG2017PTC117013
- Company No.
117013
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rikvin Biotech Private Limited offer?
Rikvin Biotech Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Feed Additives, Animal Feed Supplement, Poultry Feed, Medical Laboratory Instruments, VTM Kit Raw Materials.
Who are the key members and board of directors at Rikvin Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laxmi Badarla  | Director | 11-May-2017 | Current |
| Trinadha Badarla | Director | 28-May-2020 | Current |
Financial Performance and Corporate Structure Insights of Rikvin Biotech.
Rikvin Biotech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 27.8% increase. The company also saw a substantial improvement in profitability, with a 59.58% increase in profit. The company's net worth Soared by an impressive increase of 79.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rikvin Biotech?
In 2021, Rikvin Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rikvin Greentech India Private LimitedActive 6 years 2 daysLaxmi Badarla and Trinadha Badarla are mutual person
- Chaitra Universal Formulations Private LimitedActive 10 years 5 months
Laxmi Badarla and Trinadha Badarla are mutual person
- Rainbow Healthcare Products Private LimitedActive 1 year 4 months
Laxmi Badarla and Trinadha Badarla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 12 Jan 2024 | ₹1.05 Cr | Open |
Axis Bank Limited Creation Date: 17 Nov 2021 | ₹5.00 M | Satisfied |
How Many Employees Work at Rikvin Biotech?
Unlock and access historical data on people associated with Rikvin Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rikvin Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rikvin Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
